NCT07119255 Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper Trapezius
| NCT ID | NCT07119255 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indonesia University |
| Condition | Neck Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-09-01 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn whether pharmacopuncture with Platelet-Rich Plasma (PRP) is effective for treating chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. The main questions it aims to answer are: 1. Is pharmacopuncture with Platelet-Rich Plasma (PRP) effective in reducing chronic neck pain in patients with cervical myofascial syndrome related to the upper trapezius muscle? 2. Does PRP pharmacopuncture improve functional outcomes and quality of life in these patients? 3. Are there any adverse effects associated with PRP pharmacopuncture in this context? Researchers will compare PRP pharmacopuncture to normal saline pharmacopuncture (placebo) to evaluate whether PRP provides greater effectiveness in reducing chronic neck pain in cervical myofascial syndrome related to the upper trapezius muscle. Participants will: * Receive a single session of pharmacopuncture therapy * Undergo evaluations at week 2, week 4, and week 8 after the intervention
Eligibility Criteria
Inclusion Criteria: * Male or female, aged 18 to 59 years. * Experiencing neck pain for more than 3 months (chronic). * Neck pain classified as Grade I to III according to the Neck Pain Task Force classification. * Presence of referred pain pattern on physical examination consistent with the distribution of the upper trapezius muscle. * Visual Analogue Scale (VAS) score between 30 and 70 mm (out of 100 mm) during activity (e.g., daily activities or light exercise). * Willing to participate in the study until completion and has signed the informed consent form. Exclusion Criteria: * Hemoglobin level \<13 g/dL for males or \<12 g/dL for females. * Platelet count \<150,000/μL. * Presence of fever (≥37.5°C). * Diagnosis of fibromyalgia. * Structural abnormalities of the cervical spine other than degenerative changes, such as fractures, cervical spine injuries, space-occupying lesions (SOL), infections, neoplasms, or systemic diseases confirmed by radiographic imaging. * History of cervical spine surgery. * Presence of tumors, wounds, or skin infections at the needle insertion site. * Diagnosed with blood disorders or currently taking anticoagulant or antiplatelet medications. * History of hypersensitivity reactions to acupuncture (e.g., metal allergy, severe atopy, keloids, or other skin hypersensitivities). * Uncontrolled cardiovascular disease or diabetes mellitus. * History of pharmacopuncture therapy to the upper trapezius muscle within the past 6 months. * Use of anti-inflammatory medication within the past 2 weeks. * Currently pregnant or breastfeeding.
Contact & Investigator
KEPK FKUI-RSCM
PRINCIPAL INVESTIGATOR
The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM
Frequently Asked Questions
Who can join the NCT07119255 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 59 Years, studying Neck Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07119255 currently recruiting?
Yes, NCT07119255 is actively recruiting participants. Contact the research team at i.nareswarifkuirscm@yahoo.com for enrollment information.
Where is the NCT07119255 trial being conducted?
This trial is being conducted at Jakarta, Indonesia.
Who is sponsoring the NCT07119255 clinical trial?
NCT07119255 is sponsored by Indonesia University. The principal investigator is KEPK FKUI-RSCM at The Ethics Committee of the Faculty of Medicine, University of Indonesia - RSCM. The trial plans to enroll 72 participants.